Roche gets USFDA clearance for highly-sensitive test to aid clinicians in diagnosing B-cell lymphoma Ruchika Sharma14 Jan 2025 4:06 PM ISTBasel: Roche has announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its...
Federal Court brings end to Roundup litigation in Australia: Bayer Ruchika Sharma6 Jan 2025 10:00 AM ISTLeverkusen: Bayer has announced that the Federal Court of Australia brought an end to the last Roundup case in Australia, closing all pending...
Bayer ordered to pay USD 1.56 billion in latest US trial loss over Roundup weedkiller Ruchika Sharma20 Nov 2023 1:30 PM ISTA Missouri jury ordered Bayer to pay $1.56 billion to four plaintiffs who claimed the company's Roundup weedkiller caused injuries including...
Innovative Therapy Boosts Natural Killer Cells to Fight Blood Cancers: Study Medha Baranwal29 Oct 2023 3:00 PM ISTUSA: Medical researchers at the University of Minnesota have developed an experimental method for treating hard-to-treat blood cancers using natural...
Merkel Cell Carcinoma patients have high risk of subsequent cancers Isra Zaman18 Sept 2023 10:00 AM ISTA recent cohort study published in JAMA Dermatology found that patients with Merkel Cell Carcinoma or MCC had an increased risk of subsequently...
Roche gets USFDA priority review for Glofitamab to treat relapsed or refractory large B-cell lymphoma Ruchika Sharma7 Jan 2023 2:30 PM ISTGlofitamab is an investigational CD20xCD3 T-cell-engaging bispecific antibody designed to target CD3 on the surface of T-cells and CD20 on the surface...
AstraZeneca concludes acquisition of TeneoTwo Ruchika Sharma15 Aug 2022 11:00 AM ISTAstraZeneca has acquired all outstanding equity of TeneoTwo in exchange for an upfront payment of $100m.
AstraZeneca broadens haematological cancer pipeline with TeneoTwo acquisition Ruchika Sharma6 July 2022 12:30 PM ISTAstraZeneca will acquire all outstanding equity of TeneoTwo in exchange for an upfront payment of $100m on deal closing.
Phase 3 SHINE results show postive results for IMBRUVICA (ibrutinib) in Mantle Cell Lymphoma Ruchika Sharma5 Jun 2022 3:00 PM ISTMCL is a type of aggressive, rare non-Hodgkin lymphoma (NHL) that is incurable and difficult to treat.
Understanding Lymphoma (Blood Cancer) Dr Meet Kumar8 Oct 2021 3:22 PM ISTIn this video, Hematologist Dr. Meet Kumar explains the disease and its management
Judge suggests Bayer add warning label as part of USD 2 billion Roundup claims plan Ruchika Sharma21 May 2021 10:00 AM ISTNew Delhi: A U.S. judge suggested on Wednesday that Bayer AG include a warning label on Roundup as part of a proposed $2 billion settlement to...
